Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia

• Main Authors: Yan, J., Jiang, N., Huang, G., Tay, J.L.-S., Lin, B., Bi, C., Koh, G.S., Li, Z., Tan, J., Chung, T.-H., Lu, Y., Ariffin, H., Kham, S.K.Y., Yeoh, A.E.J., Chng, W.-J.
• 其他作者: CANCER SCIENCE INSTITUTE OF SINGAPORE
• 格式: Article
• 出版: 2014
• 主題: Clinical outcome; MAPK1; MIR335; Paediatric acute lymphoblastic leukaemia; Prednisolone
• 在線閱讀: http://scholarbank.nus.edu.sg/handle/10635/110731

10.1111/bjh.12489